ロード中...
Peroxisome Proliferator-Activated Receptor γ Controls Ingestive Behavior, Agouti-Related Protein, and Neuropeptide Y mRNA in the Arcuate Hypothalamus
Peroxisome proliferator-activated receptor γ (PPARγ) is clinically targeted for type II diabetes treatment; however, rosiglitazone (ROSI), a PPARγ agonist, increases food intake and body/fat mass as side-effects. Mechanisms for these effects and the role of PPARγ in feeding are not understood. There...
保存先:
| 出版年: | J Neurosci |
|---|---|
| 主要な著者: | , , , , , |
| フォーマット: | Artigo |
| 言語: | Inglês |
| 出版事項: |
Society for Neuroscience
2015
|
| 主題: | |
| オンライン・アクセス: | https://ncbi.nlm.nih.gov/pmc/articles/PMC4363385/ https://ncbi.nlm.nih.gov/pubmed/25788674 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1523/JNEUROSCI.2129-14.2015 |
| タグ: |
タグ追加
タグなし, このレコードへの初めてのタグを付けませんか!
|